PET imaging for tau-related brain diseases
Part of Brain & nervous system, Mental health clinical trials.
This trial uses a special imaging agent called [18F]NIDF to take pictures of tau protein clumps in the brain, which are linked to Alzheimer's and other memory or movement disorders. It may help doctors see these changes more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You are either healthy or have been diagnosed with probable Alzheimer's disease or another condition causing dementia.
- You do not have other serious diseases like advanced cancer, kidney or liver failure.
- You are not allergic to the imaging agent or its ingredients.
- You are not pregnant or breastfeeding.
- You can have a PET scan and a small injection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special scan (Tau PET/CT) to look at tau protein in the brain or body. It may help doctors understand tau-related diseases better, and is open to adults who are scheduled for this scan.
This study uses a special PET/CT brain scan to look at a protein called tau in people with memory/thinking and movement disorders. The results may help researchers understand how these diseases affect the brain and improve future diagnosis or care.
This study uses a special PET scan to see how a new tracer (18F-JSS20-183A) moves through the body and brain. It may help researchers learn more about brain diseases like Parkinson's and Alzheimer's.
This trial uses a special PET scan to see how a new imaging agent (called 11C-M503) travels through the body and brain. It may help researchers better understand brain conditions like Parkinson's disease.
This trial tests a radioactive imaging agent that targets a protein in the brain linked to inflammation, to see if it can help track Alzheimer's disease. It may help doctors better understand your condition and guide future treatments.
This study uses a PET brain scan with a small injected tracer to look for “tau” protein changes linked to Alzheimer’s disease. It may help researchers better understand how tau appears in people who are cognitively normal or have mild dementia.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.